{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T18:39:14Z","timestamp":1771526354486,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015283","name":"Bloomberg Philanthropies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.josat.2025.209711","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:11:16Z","timestamp":1745899876000},"page":"209711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Use of harm reduction practices by state-licensed specialty substance use treatment programs"],"prefix":"10.1016","volume":"174","author":[{"given":"Isha K.","family":"Desai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Ganetsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia K.","family":"Sugarman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noa","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Feder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209711_bb0005","author":"Aronowitz"},{"key":"10.1016\/j.josat.2025.209711_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209351","article-title":"Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership","volume":"162","author":"Burke","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"9","key":"10.1016\/j.josat.2025.209711_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.2807","article-title":"Disparities in medication use for criminal justice system\u2013referred opioid use disorder treatment","volume":"5","author":"Donahoe","year":"2024","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.josat.2025.209711_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209545","article-title":"Client and program-level factors associated with planned use of medications for opioid use disorder in specialty substance use treatment programs: Evidence from linked administrative data and survey data","volume":"168","author":"Feder","year":"2025","journal-title":"Journal of Substance Use & Addiction Treatment"},{"key":"10.1016\/j.josat.2025.209711_bb0025","unstructured":"Ganetsky, V. S., Feder, K. A., Burke, K. N., Desai, I. K., Harris, S. J., & Krawczyk, N. (n.d.). Integration of harm reduction principles and practices within specialty substance use treatment programs in New Jersey: A qualitative study of program leadership. In preparation."},{"issue":"4","key":"10.1016\/j.josat.2025.209711_bb0030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1037\/xge0000920","article-title":"Logistic or linear? Estimating causal effects of experimental treatments on binary outcomes using regression analysis","volume":"150","author":"Gomila","year":"2021","journal-title":"Journal of Experimental Psychology: General"},{"key":"10.1016\/j.josat.2025.209711_bb0035","series-title":"Harm Reduction Services Improve Health Equity & Save Lives","year":"2023"},{"issue":"6","key":"10.1016\/j.josat.2025.209711_bb0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/ADM.0000000000000983","article-title":"Take-home naloxone at opioid treatment programs: A lifesaver","volume":"16","author":"Katzman","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2025.209711_bb0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12954-023-00736-7","article-title":"Racial\/ethnic disparities in opioid overdose prevention: Comparison of the naloxone care cascade in white, latinx, and black people who use opioids in New York City","volume":"20","author":"Khan","year":"2023","journal-title":"Harm Reduction Journal"},{"issue":"4","key":"10.1016\/j.josat.2025.209711_bb0050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1377\/hlthaff.2020.01251","article-title":"Medicaid expansion increased medications for opioid use disorder among adults referred by criminal justice agencies","volume":"40","author":"Khatri","year":"2021","journal-title":"Health Affairs (Project Hope)"},{"issue":"1","key":"10.1016\/j.josat.2025.209711_bb0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12954-022-00676-8","article-title":"Intersecting substance use treatment and harm reduction services: Exploring the characteristics and service needs of a community-based sample of people who use drugs","volume":"19","author":"Krawczyk","year":"2022","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2025.209711_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111067","article-title":"Association of random and observed urine drug screening with long-term retention in opioid treatment programs","volume":"255","author":"Michener","year":"2024","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209711_bb0065","author":"Purington"},{"key":"10.1016\/j.josat.2025.209711_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.00501","article-title":"Community care in reach: Mobilizing harm reduction and addiction treatment services for vulnerable populations","volume":"8","author":"Regis","year":"2020","journal-title":"Frontiers in Public Health"},{"issue":"7","key":"10.1016\/j.josat.2025.209711_bb0075","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/amajethics.2024.562","article-title":"How should harm reduction be included in care continua for patients with opioid use disorder?","volume":"26","author":"Salisbury-Afshar","year":"2024","journal-title":"AMA Journal of Ethics"},{"key":"10.1016\/j.josat.2025.209711_bb0080","author":"SAMHSA"},{"issue":"5","key":"10.1016\/j.josat.2025.209711_bb0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1377\/hlthaff.2019.01085","article-title":"Impact of long-term buprenorphine treatment on adverse health care outcomes in Medicaid","volume":"39","author":"Samples","year":"2020","journal-title":"Health Affairs"},{"issue":"4","key":"10.1016\/j.josat.2025.209711_bb0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0740-5472(03)00085-0","article-title":"Harm reduction psychotherapy: Extending the reach of traditional substance use treatment","volume":"25","author":"Tatarsky","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.josat.2025.209711_bb0095","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1007\/s11606-021-06904-4","article-title":"Integrating harm reduction into outpatient opioid use disorder treatment settings","volume":"36","author":"Taylor","year":"2021","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2025.209711_bb0100","series-title":"U.S. Overdose Deaths Decrease in 2023, First Time Since 2018","year":"2024"},{"issue":"2","key":"10.1016\/j.josat.2025.209711_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:06:02Z","timestamp":1761840362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":21,"alternative-id":["S2949875925000906"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209711","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of harm reduction practices by state-licensed specialty substance use treatment programs","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209711"}}